Fj. Moy et al., PROPERLY ORIENTED HEPARIN-DECASACCHARIDE-INDUCED DIMERS ARE THE BIOLOGICALLY-ACTIVE FORM OF BASIC FIBROBLAST GROWTH-FACTOR, Biochemistry, 36(16), 1997, pp. 4782-4791
Interaction of basic fibroblast growth factor (FGF-2) with heparin or
heparan sulfate proteoglycans (HSPGs) is required for receptor activat
ion and initiation of biological responses. To gain insight into the m
echanism of activation of the FGF receptor by FGF-2 and heparin, we ha
ve used NMR, dynamic light scattering, and HSPG-deficient cells and ce
ll-free systems. The first 28 N-terminal residues in FGF-2 were found
to be highly mobile and flexible, consistent with the disorder found i
n both the NMR and X-ray structures. The structure of an FGF-2-heparin
-decasaccharide complex that binds to and activates the FGF receptor w
as compared to a heparin-tetrasaccharide-induced complex that does not
promote an interaction with the receptor. The major change observed u
pon the addition of the tetrasaccharide to FGF-2 was an increase in th
e correlation time consistent with the formation of an FGF-2 dimer. Th
e NMR line widths of FGF-2 in the presence of the decasaccharide are s
everely broadened relative to the tetrasaccharide, consistent with dyn
amic light scattering results which indicate FGF-2 is a tetramer. The
interaction of these heparin species with FGF-2 does not induce a sign
ificant conformational change in the overall structure of FGF-2, but s
mall chemical shift changes are observed in both heparin and receptor
binding sites. A trans-oriented symmetric dimer of FGF-2 is formed in
the presence of the tetrasaccharide whereas two cis-oriented dimers in
a symmetric tetramer are formed in the presence of the decasaccharide
. This suggests that the cis-oriented FGF-2 dimer is the minimal biolo
gically active structural unit of FGF-2. These data allow us to propos
e a novel mechanism to explain the functional interaction of FGF-2 wit
h heparin and its transmembrane receptor.